In 2023, Japan's government budget appropriations or outlays for R&D in health stood at a substantial value, setting the stage for future forecasts. From 2024 to 2028, there is a consistent upward trajectory, starting with $50 billion PPP in 2024 and reaching $57.9 billion PPP by 2028.
The year-on-year growth showcases a stable increase, averaging around a 3-4% rise annually, reflecting a positive commitment to health R&D investment. This results in a compound annual growth rate (CAGR) of approximately 3.7% over the five-year period.
Future trends to watch for include the potential impact of demographic shifts, such as an aging population, which could further drive R&D investments. Additionally, technological advancements and policy shifts towards innovation-driven healthcare solutions may accelerate budget allocations.
